^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Title:

Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report

Published date:
12/18/2020
Excerpt:
We diagnosed her with metastatic breast cancer, positive for HER2....The results of circulating tumor DNA assays showed that other than HER2 amplification, novel EGFR-ZNF880 fusion and EGFR E114K mutations developed....This case report demonstrates that EGFR-ZNF880 fusion and EGFR E114K mutations may contribute or lead to the formation of a special HER2 dimer, which is rapidly resistant to lapatinib but sensitive to pyrotinib.
DOI:
10.1097/MD.0000000000023406